SCHEMBL29736699

SCHEMBL29736699

Cn1cc(-c2cc(Oc3ccc(N)cc3Cl)ccn2)cn1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 18/20 0.48
▸ PDGFRA P16234 12/20 0.48
▸ PDGFRB P09619 7/20 0.48
▸ FLT3 P36888 4/20 0.48
▸ KDR P35968 3/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ AXL P30530 1/20 0.47
▸ KIT P10721 2/20 0.47
▸ LCK P06239 1/20 0.47
▸ PTK6 Q13882 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413394 1.00 CSF1R (0.48) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL2030714 0.87 CSF1R (0.52) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL29736796 0.87 CSF1R (0.52) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL29736560 0.86 CSF1R (0.55) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL29736609 0.86 CSF1R (0.50) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL23071266 0.86 CSF1R (0.50) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL2418677 0.86 CSF1R (0.55) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL2414132 0.84 KDR (0.48) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL574068 0.83 KDR (0.52) CSF1RPDGFRAPDGFRBFLT3KDR
SCHEMBL29736768 0.83 KDR (0.52) CSF1RPDGFRAPDGFRBFLT3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283916-B Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof 中国科学院上海药物研究所 2024-06-11 — — CN disclosed
CN-116283916-A Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof 中国科学院上海药物研究所 2023-06-23 — — CN disclosed
CN-112457295-B Compound with Axl and c-Met kinase inhibitory activity and preparation and application thereof 中国科学院上海药物研究所 2022-07-26 — — CN disclosed
EP-4029862-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-07-20 — — EP disclosed
Send feedback